Literature DB >> 25486310

PURLs: prescribing statins for patients with ACS? No need to wait.

Hanna Gov-Ari1, James J Stevermer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25486310      PMCID: PMC4294411     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  6 in total

1.  2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.

Authors:  R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; James Patrick Zidar
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

Review 2.  Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Eliano Pio Navarese; Mariusz Kowalewski; Felicita Andreotti; Marleen van Wely; Cyril Camaro; Michalina Kolodziejczak; Bartosz Gorny; Jeffrey Wirianta; Jacek Kubica; Malte Kelm; Menko-Jan de Boer; Harry Suryapranata
Journal:  Am J Cardiol       Date:  2014-03-02       Impact factor: 2.778

3.  Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.

Authors:  M Pignone; C Phillips; C Mulrow
Journal:  BMJ       Date:  2000-10-21

Review 4.  Beyond lipid lowering: the role of statins in vascular protection.

Authors:  James K Liao
Journal:  Int J Cardiol       Date:  2002-11       Impact factor: 4.164

5.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

6.  Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.

Authors:  Jie Li; Jian-Jun Li; Jian-Guo He; Jing-long Nan; Yuan-lin Guo; Chang-ming Xiong
Journal:  Cardiovasc Ther       Date:  2010       Impact factor: 3.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.